CRBU (STOCKS)
Caribou Biosciences, Inc. Common Stock
$1.970000
+0.040000 (+2.07%)
Prev close: $1.930000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Rachel E. Haurwitz
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $188.93M
- Employees
- 147
- P/E (TTM)
- -1.21
- P/B (TTM)
- 1.50
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $11.16M |
| Benefits Costs and Expenses | $159.83M |
| Costs And Expenses | $159.83M |
| Nonoperating Income/Loss | -$331.00K |
| Operating Expenses | $159.50M |
| Research and Development | $109.44M |
| Other Operating Expenses | $50.06M |
| Operating Income/Loss | -$148.34M |
| Income/Loss From Continuing Operations After Tax | -$148.13M |
| Income/Loss From Continuing Operations Before Tax | -$148.68M |
| Income Tax Expense/Benefit | -$550.00K |
| Income Tax Expense/Benefit, Current | $1.00K |
| Income Tax Expense/Benefit, Deferred | -$551.00K |
| Net Income/Loss | -$148.13M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$148.13M |
| Net Income/Loss Available To Common Stockholders, Basic | -$148.13M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.59 |
| Diluted Earnings Per Share | -$1.59 |
| Basic Average Shares | 93,389,283 |
| Diluted Average Shares | 93,389,283 |
| Assets | $175.37M |
| Current Assets | $145.23M |
| Cash | $142.80M |
| Other Current Assets | $2.43M |
| Noncurrent Assets | $30.14M |
| Fixed Assets | $6.76M |
| Other Non-current Assets | $23.38M |
| Liabilities | $53.19M |
| Current Liabilities | $25.41M |
| Accounts Payable | $5.78M |
| Wages | $6.11M |
| Other Current Liabilities | $13.52M |
| Noncurrent Liabilities | $27.78M |
| Equity | $122.18M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $122.18M |
| Liabilities And Equity | $175.37M |
| Net Cash Flow From Operating Activities | -$110.99M |
| Net Cash Flow From Operating Activities, Continuing | -$110.99M |
| Net Cash Flow From Investing Activities | $102.24M |
| Net Cash Flow From Investing Activities, Continuing | $102.24M |
| Net Cash Flow From Financing Activities | $4.82M |
| Net Cash Flow From Financing Activities, Continuing | $4.82M |
| Net Cash Flow | -$3.93M |
| Net Cash Flow, Continuing | -$3.93M |
| Comprehensive Income/Loss | -$148.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$148.28M |
| Other Comprehensive Income/Loss | -$152.00K |
| Other Comprehensive Income/Loss Attributable To Parent | -$152.00K |